Enko running shoes promised a dramatic departure from conventional footwear. Instead of relying mainly on foam cushioning, they incorporated a conspicuous mechanical suspension system beneath the foot. Their springs and articulated soles attracted attention from runners, designers and technology enthusiasts. However, the anticipated footwear revolution never materialised. The clearest answer to what happened is financial: the French company entered judicial liquidation in September 2019. Its story illustrates the difference between developing an intriguing invention and establishing a sustainable running-shoe business.

An ambitious mechanical alternative

Enko was developed by French engineer and runner Christian Freschi, who reportedly spent approximately twelve years refining the concept before its emergence in international coverage in 2015. An Indiegogo campaign helped introduce the shoes to potential customers. Their appeal was immediately understandable: if suspension protected cyclists from uneven surfaces, perhaps a comparable mechanism could make running more comfortable. Rather than resembling ordinary trainers, Enko shoes looked like compact machines attached to the feet.

The design used springs and a moving sole structure to compress under loading and rebound as the runner progressed through each step. Spring options were matched to the user’s body weight. The later G4 model offered seven cushioning categories covering runners weighing approximately 45–115 kilograms. A lever selected walking or running modes, while replaceable outsole studs were intended to extend service life. Enko promoted substantial shock absorption and durability, including a claimed lifespan of around 2,000 kilometres.

These features were genuinely distinctive, but the promotional language required caution. A spring can store and return mechanical energy; it cannot create energy. Furthermore, visible rebound does not establish that a shoe reduces the metabolic cost of running. Any benefit depends on the timing and direction of energy return, shoe weight, stability and the runner’s response. Similarly, reducing an impact measurement does not automatically demonstrate fewer injuries. Running injuries reflect interacting factors, including training load, tissue capacity and previous injury. Establishing clinical advantages would have required comparative studies following runners over time, rather than relying on demonstrations, testimonials or laboratory measurements of the suspension mechanism considered separately from its wearer.

Promise met practical compromises

Enko was more than a prototype that disappeared before reaching consumers. A July 2018 review in Canadian Running described running in the G4 and reported a noticeable spring-assisted sensation, a comfortable upper and a smooth transition towards the forefoot. The reviewer considered it potentially useful for longer, easier runs. These observations help explain why the shoes developed an interested audience: some runners genuinely enjoyed their unusual cushioning rather than merely admiring the engineering.

Nevertheless, the same review revealed significant compromises. The tested women’s size 8.5 weighed about 380 grams, substantial for performance running footwear. The reviewer also felt that the spring’s reloading limited rapid stride turnover and did not recommend the shoes for speed training. Walking initially felt awkward, and temporary calf tightness occurred during adaptation. Such observations are individual experiences, not controlled evidence, but they demonstrate that the suspension changed more than underfoot softness. It also changed the practical running experience.

Price presented another obstacle. The G4 retailed for approximately C$492 in that review, making it an expensive experiment for runners accustomed to conventional shoes. Promised durability could theoretically offset the purchase price, but buyers also needed confidence in replacement parts, warranties and continuing support. A shoe with specialised moving components creates different ownership expectations from a straightforward foam-soled trainer. These characteristics plausibly constrained its appeal, although the available records do not establish their individual contributions to the company’s failure.

The documented end of the business

The company’s disappearance is not simply an inference from an inactive website. French corporate records reproduced by Pappers identify ENKO, company number 799369855, as entering judicial liquidation on 11 September 2019. The court fixed its cessation-of-payments date at 9 August 2019, and the record states that activity ceased completely. On 1 March 2023, the liquidation was closed for insufficient assets. The company was removed from the commercial register on 2 March 2023. These dates distinguish the operational collapse from its later administrative conclusion.

What those records do not provide is a detailed commercial post-mortem. It would therefore be misleading to claim confidently that Enko failed because the shoes were ineffective, because runners rejected springs, or because a sporting authority banned the business. Financial insolvency is documented; the precise combination of sales, production costs, financing and operational difficulties is not established by the sources reviewed. Equally, enthusiastic product coverage should not be mistaken for independent proof of injury prevention or superior running economy.

Ultimately, Enko’s fate was the closure of an ambitious footwear venture, not a definitive scientific rejection of mechanical cushioning. Its shoes offered a striking alternative but combined novelty with weight, expense and unfamiliar mechanics. Their lasting lesson is that successful running footwear must deliver more than an impressive rebound: it needs convincing benefits, everyday usability, dependable support and a business capable of surviving beyond the initial excitement.

Sources

• Pappers: ENKO company record and liquidation notices.
• Canadian Running: “Shoe Review: ENKO G4,” 20 July 2018.
• Core77: “Enko’s Energy-Returning Running Shoes,” 21 January 2015.

A Durlacher corn is a small, often intensely painful lesion that develops beside the toenail, usually along the outer edge of the fifth, or little, toe. Also called a Lister’s corn, it occupies the narrow space between the nail and the surrounding skin. Its position distinguishes it from the more familiar corn over a toe joint or beneath the forefoot. Although easily overlooked, it can make ordinary footwear uncomfortable and walking unpleasant. Understanding this condition requires attention to local pressure, toe structure, and the possibility that an apparent corn is actually an accessory portion of toenail.

Development and causes

Conventionally, a Durlacher corn is described as a localised area of hyperkeratosis: thickening of the outer skin layer in response to repeated mechanical stress. Pressure and friction stimulate keratin accumulation, producing a compact lesion that presses into sensitive underlying tissues. The narrow nail groove leaves little room for this extra material, so even a tiny lesion may cause considerable pain. A corn does not have a true root, although its dense central keratin can resemble one. Removing that material can relieve discomfort, but does not necessarily eliminate the forces responsible for its formation.

Footwear is an important contributor. Narrow toe boxes squeeze the little toe against the shoe, while firm seams or stiff uppers can concentrate pressure beside the nail. Toe deformity may increase this loading. A fifth toe that rotates inward can expose its outer nail margin to pressure from both footwear and the ground. Prominent underlying bone, reduced soft tissue cushioning, and stiffness may also contribute. Fusion of the middle and distal toe bones, termed symphalangism, has been associated with these lesions in clinical reports, although its precise importance has not been established through strong comparative research.

Symptoms and diagnosis

Patients commonly describe a sharp, focal pain at the edge of the little toenail, particularly when wearing enclosed shoes. The lesion may look like a hard sliver, an additional nail fragment, or a small yellowish thickening. Some people therefore assume that they have an ingrown toenail or fungal infection. Diagnosis usually involves careful inspection and palpation, assessment of footwear, and examination of toe alignment. A podiatrist also considers alternative explanations, including an ingrown nail, wart, foreign body, or another nail disorder. Persistent ulceration, bleeding, unusual pigmentation, or unexplained enlargement warrants further investigation rather than repeated routine corn treatment.

Assessment should also include circulation and sensation, because these influence treatment safety. The clinician should ask when symptoms occur, whether both feet are affected, and whether previous removal produced lasting relief or only a relatively brief improvement.

An important diagnostic qualification is that not everything labelled a Durlacher corn is necessarily thickened skin. Published descriptions of accessory fifth toenails show that a small additional nail plate can lie beside the main nail and resemble a corn. Histological examination in reported cases has confirmed genuine nail tissue. These accessory nails may have an associated groove or split and can occur on both feet. Consequently, clinicians should distinguish pressure-induced hyperkeratosis from a developmental nail variation, while recognising that both may coexist. This distinction matters because recurrent nail tissue will not be permanently resolved by treating it as ordinary callus.

Treatment and prevention

Initial management generally aims to reduce pressure and relieve symptoms. Shoes should provide sufficient width and depth around the toes, with soft uppers and minimal irritating seams. Carefully selected padding or a silicone toe protector may help, provided it does not make the shoe tighter. Professional reduction of a true corn can provide substantial relief by removing compacted keratin. However, recurrence is common if footwear pressure or toe deformity remains unchanged. Regular review may therefore be appropriate. Moisturising dry surrounding skin can improve comfort, but cannot correct a bony prominence or remove an accessory nail-producing structure.

Self-treatment requires caution. Digging beside the nail with blades, scissors, or sharp instruments can damage skin and introduce infection. Acid-containing corn removers may burn adjacent healthy tissue, especially in the confined nail groove. People with diabetes, neuropathy, poor circulation, or a previous foot ulcer should seek professional assessment rather than attempting removal themselves. Redness, warmth, swelling, drainage, or an open wound requires prompt clinical attention. Persistent pain despite appropriate footwear and conservative care may justify imaging or specialist assessment, particularly when an underlying bony prominence, substantial toe deformity, or accessory nail is suspected.

Surgery is reserved for selected, persistently symptomatic cases and should address the actual diagnosis. Options may include correcting a focal bony prominence or toe deformity, or removing a painful accessory nail with appropriate treatment of its matrix. Potential complications include infection, delayed healing, nail distortion, and recurrence. Evidence specific to Durlacher corns consists largely of clinical descriptions and small reports, so outcomes should not be overstated. Ultimately, successful management depends on identifying whether the problem is corn, nail, or both, reducing mechanical irritation, and choosing treatment proportionate to symptoms and risk.

References

• Haneke, E. (2015). Double nail of the little toe. Skin Appendage Disorders, 1(4), 163–167.
• Fishco, W. D. (2011). Key considerations in treating Lister’s corn. Podiatry Today.
• Alder, D. C., Fishco, W. D., & Ruch, J. A. (1998). Surgical treatment of Lister’s corn: A case illustration. Journal of the American Podiatric Medical Association, 88(1), 30–33.

Limited joint mobility is an often overlooked musculoskeletal complication of diabetes mellitus. It involves progressive stiffness and reduced movement, particularly in the small joints of the hands and feet. When the hands are affected, the condition is commonly called diabetic cheiroarthropathy or diabetic stiff hand syndrome. Although usually less immediately threatening than cardiovascular disease or kidney failure, it can interfere with everyday activities, alter walking mechanics, and contribute to diabetic foot problems. Recognising this condition is therefore important for preserving function and identifying people who may need closer assessment for other diabetes complications.

Causes and underlying mechanisms

Limited joint mobility occurs in both type 1 and type 2 diabetes. Its reported prevalence varies considerably because studies use different definitions, examination methods, and patient populations. Longer diabetes duration and greater cumulative exposure to hyperglycaemia are important associations, although ageing and other musculoskeletal conditions also influence joint movement. The condition is not inevitable, and restricted movement in someone with diabetes should not automatically be attributed to it.

The principal proposed mechanism is the effect of chronic hyperglycaemia on connective tissue. Glucose attaches to proteins through non-enzymatic glycation, eventually producing advanced glycation end products. These accumulate in long-lived proteins such as collagen, which provides structural support in skin, tendons, ligaments, and joint capsules. Additional collagen cross-linking makes these tissues less elastic and more resistant to normal turnover. Consequently, structures surrounding the joints become thicker and stiffer, progressively restricting movement.

Other mechanisms may contribute, including altered collagen metabolism, oxidative stress, inflammation, and microvascular dysfunction. These processes can affect tissue quality and repair. However, the relative contribution of each remains uncertain, and limited joint mobility is better understood as a multifactorial connective-tissue disorder than simply the result of one biochemical pathway.

Clinical presentation and diagnosis

In the hands, limited joint mobility typically develops gradually and is often painless. The fingers become difficult to straighten fully, and fixed flexion contractures may develop. The overlying skin can appear thickened, tight, and waxy. Reduced grip strength and dexterity may make writing, fastening buttons, opening containers, or managing diabetes equipment more difficult. Nevertheless, some people have obvious examination findings without noticing substantial disability.

Two simple clinical manoeuvres help identify hand involvement. In the prayer sign, the person presses the palms and fingers together; incomplete contact between opposing fingers suggests restricted extension. In the tabletop sign, the person cannot place the palm and fingers completely flat on a table. These findings support assessment but are not uniquely diagnostic of diabetic cheiroarthropathy. Examination should include active and passive movement, skin changes, pain, and functional limitations.

Other disorders must be considered, including osteoarthritis, inflammatory arthritis, systemic sclerosis, Dupuytren contracture, and trigger finger. Several can coexist with diabetes-related stiffness. Imaging and blood tests are not routinely necessary for a typical presentation but may help when symptoms suggest another diagnosis. Painful swelling, marked asymmetry, or rapid deterioration warrants further investigation rather than assuming uncomplicated limited joint mobility.

Effects on the feet and walking

Lower-limb involvement has particular clinical importance. Restricted movement may affect the ankle, subtalar joint, and metatarsophalangeal joints, especially the big toe joint. Normal walking requires these structures to accommodate the ground, allow the body to advance over the supporting foot, and enable effective propulsion. When their movement is reduced, compensatory gait patterns can develop, changing the distribution of plantar loading.

For example, restricted ankle dorsiflexion may contribute to increased forefoot loading, while limited big toe joint movement can alter push-off. These changes do not produce identical pressure patterns in everyone, but they may concentrate repeated stress beneath vulnerable areas. Callus can develop, and tissue injury becomes more likely when mechanical overload combines with peripheral neuropathy, which reduces protective sensation. Peripheral arterial disease can further compromise healing.

Limited joint mobility is therefore one contributor to diabetic foot ulcer risk, not an independent explanation for every ulcer. Assessment should integrate joint movement with sensation, circulation, deformity, footwear, skin condition, and previous ulceration. A newly hot, swollen foot requires urgent assessment for conditions such as active Charcot neuroarthropathy or infection, rather than being labelled ordinary diabetic stiffness.

Association with other complications

Research has associated limited joint mobility with diabetic retinopathy, nephropathy, and neuropathy. These relationships may reflect shared exposure to longstanding hyperglycaemia and connective-tissue changes. However, association does not establish that joint stiffness causes these complications or reliably predicts them in an individual. Its detection should prompt clinicians to check that recommended diabetes screening is current, rather than treating it as proof of underlying vascular disease.

Management and prevention

There is no established treatment that reliably reverses advanced diabetic cheiroarthropathy. Management aims to maintain movement, minimise disability, and prevent secondary problems. Individualised glucose management is important for overall health and may help prevent or slow progression, but established collagen changes and contractures should not be expected to disappear rapidly when glucose levels improve.

Physiotherapy and occupational therapy can provide gentle stretching, range-of-motion exercises, functional training, and advice about adapting daily tasks. Exercises should be tailored to the affected joints and accompanying conditions. Evidence supporting specific programmes is limited, so benefits should be described realistically. Forceful stretching is inappropriate, particularly where neuropathy, fragile skin, active ulceration, or suspected Charcot disease makes injury difficult to detect.

For foot involvement, podiatric care includes footwear assessment, callus management, and pressure redistribution when indicated. Appropriately fitted shoes, insoles, or selected rocker soles may accommodate restricted movement, but prescriptions require individual assessment. Daily foot inspection and prompt attention to skin damage remain essential. Analgesics may help coexisting painful conditions but do not reverse the underlying stiffness.

Regular review should assess practical outcomes, not merely joint angles. Important questions include whether the person can dress independently, handle medication safely, walk comfortably, and inspect their feet. Where hand stiffness prevents self-care, assistance from family members or carers may be necessary. This functional approach helps translate clinical findings into meaningful everyday support.

Limited joint mobility demonstrates how diabetes affects connective tissues as well as nerves and blood vessels. Although often painless, it can impair hand function and contribute to hazardous loading of the feet. Early recognition, appropriate differential diagnosis, coordinated rehabilitation, and preventive foot care can reduce its practical consequences and support long-term independence.

References

• Limited joint mobility syndrome in diabetes mellitus: A minireview. World Journal of Diabetes. 2015;6(9):1108–1112. PubMed.
• Smith LL, Burnet SP, McNeil JD. Musculoskeletal manifestations of diabetes mellitus. British Journal of Sports Medicine. 2003;37:30–35. PubMed.
• Starkman HS, Gleason RE, Rand LI, Miller DE, Soeldner JS. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications. Annals of the Rheumatic Diseases. 1986;45:130–135. PubMed.

Duchenne muscular dystrophy (DMD) is a progressive, X-linked genetic disorder caused by mutations affecting dystrophin, a protein that stabilises muscle fibres during contraction. It predominantly affects boys, although females can occasionally develop significant manifestations. Without adequate dystrophin, repeated muscle damage leads to degeneration and replacement of muscle tissue by fat and fibrosis. The lower limbs are particularly important because their deterioration affects walking, standing, transfers and independence. Lower-limb problems include progressive weakness, altered gait, contractures, foot deformity, pain and fractures. Understanding how these problems interact is essential for preserving function and quality of life.

Progressive Muscle Weakness

Weakness usually becomes evident in early childhood and initially affects proximal muscles, particularly the pelvic girdle and thighs. Children may struggle to run, jump, climb stairs or rise from the floor. Weakness of the hip extensors and knee extensors makes lifting the body against gravity increasingly difficult. A characteristic finding is Gowers’ sign: the child uses the hands to push against the floor and then “climbs” up the legs to reach standing. This manoeuvre compensates for insufficient proximal muscle strength rather than indicating a primary joint disorder.

The calves often appear enlarged, a feature called pseudohypertrophy. This enlargement largely reflects fatty and connective-tissue replacement and should not be mistaken for increased strength. As weakness progresses, walking becomes slower, falls become more frequent and endurance declines. Eventually, independent ambulation is lost, although timing varies considerably with disease severity and treatment. Glucocorticoids and other specialist-directed therapies can modify progression, making rigid age-based predictions inappropriate. Functional assessment should therefore focus on the individual’s abilities and changing needs.

Gait Abnormalities and Compensation

Lower-limb weakness produces recognisable compensatory gait patterns. Weak hip abductors reduce pelvic stability, contributing to a waddling gait and lateral trunk movement. Weak hip extensors encourage increased lumbar lordosis and altered trunk positioning. These adaptations help maintain balance and reduce the muscular demands of standing and walking, but they also increase energy expenditure and fatigue.

Toe walking commonly develops. Initially, ankle plantarflexion may help position the ground-reaction force anterior to the knee, supporting knee extension when the quadriceps are weak. Consequently, an unusual gait pattern is not always simply a deformity requiring correction; it may be an important compensation. Later, shortening of the calf muscles and Achilles tendon can produce fixed equinus. Reduced foot clearance, difficulty negotiating uneven surfaces and declining balance further increase fall risk. Gait assessment should distinguish flexible compensation from established contracture before treatment decisions are made.

Contractures and Foot Deformities

Contractures are persistent restrictions in joint movement caused by shortening of muscles and surrounding soft tissues. In DMD, they result from muscle imbalance, fibrosis, reduced movement and prolonged positioning. Ankle plantarflexion contractures are particularly common, while hip and knee flexion contractures become increasingly important as mobility declines. Contractures often accelerate after loss of walking because the lower limbs spend more time in flexed positions.

The feet may develop equinovarus, combining a downward-pointing ankle with inward turning of the hindfoot. Progressive deformity can impair shoe fitting, standing, transfers and positioning on wheelchair footplates. Abnormal loading may cause focal pressure, callus and discomfort. After independent walking is lost, maintaining comfortable foot alignment remains valuable for supported standing, skin protection and everyday care. Sensation is generally preserved, unlike in peripheral neuropathy, but limited movement can prevent effective pressure relief. Footwear and orthoses require regular checks for fit and skin irritation.

Bone Fragility, Fractures and Pain

Bone health is another major concern. Reduced weight-bearing and muscle forces diminish the stimulus for bone development, while long-term glucocorticoid treatment can further compromise skeletal strength. Delayed puberty and nutritional difficulties may contribute. Consequently, relatively minor trauma can cause lower-limb fractures, particularly involving the femur. A fracture may have consequences beyond the immediate injury: immobilisation can accelerate weakness and contracture, and a child with marginal walking ability may not recover previous ambulation.

Management requires prompt assessment and a plan that minimises unnecessary immobilisation while respecting fracture stability. Bone surveillance, adequate calcium intake and correction of vitamin D deficiency form part of comprehensive care. Established fragility fractures warrant specialist osteoporosis assessment, with intravenous bisphosphonates considered where indicated. Pain may also arise from muscle fatigue, contractures, poor seating or pressure from footwear. New focal pain should not automatically be attributed to muscular dystrophy, particularly after a fall or transfer incident.

Rehabilitation and Clinical Management

Management aims to preserve function, prevent avoidable secondary complications and maintain comfort, rather than reverse the underlying muscle disorder. Regular physiotherapy assessment should monitor joint range, muscle function, gait, fatigue and transfers. Gentle stretching of vulnerable muscle groups, especially the plantarflexors, hamstrings and hip flexors, is commonly recommended. Night-time ankle–foot orthoses may help maintain ankle positioning, provided they are comfortable and appropriately fitted. Evidence supporting particular contracture interventions is limited, so treatment requires individual review rather than assuming guaranteed benefit.

Submaximal activity, such as supported swimming or appropriately adapted cycling, can encourage participation without excessive loading. High-resistance exercise and strenuous eccentric activity should be avoided because dystrophin-deficient muscle is vulnerable to damage. Rest periods, accessible environments and mobility aids help conserve energy. Rigid daytime ankle bracing can interfere with compensatory walking and should not be prescribed indiscriminately. Supported standing may assist positioning and participation, but requires assessment of contractures, tolerance and fracture risk.

Surgery is reserved for selected situations. Correcting ankle deformity may occasionally benefit a person with sufficient remaining strength or improve positioning after ambulation is lost. However, excessive Achilles tendon lengthening can remove useful compensation and worsen walking. Decisions require coordinated neuromuscular, rehabilitation and orthopaedic input, alongside careful cardiac, respiratory and anaesthetic assessment.

As wheelchair use increases, seating and lower-limb support should accommodate changing posture without forcing painful correction. Caregivers need training in safe transfers and repositioning to reduce injury and pressure damage. Physiotherapists, occupational therapists, orthotists and podiatrists can collaborate on practical solutions. The person’s priorities should guide intervention, balancing potential functional gains against discomfort, treatment burden and disruption to school or family life.

Lower-limb problems in Duchenne muscular dystrophy reflect interacting muscle weakness, compensatory biomechanics, soft-tissue shortening and skeletal fragility. Their effects extend beyond walking to comfort, transfers, participation and independence. Individualised multidisciplinary care can limit secondary complications and support meaningful function throughout changing disease stages.

References

• Apkon, S. D., et al. (2018). Orthopedic and surgical management of the patient with Duchenne muscular dystrophy. Pediatrics, 142(Supplement 2), S82–S89. https://doi.org/10.1542/peds.2018-0333J
• Balachandran, U., Mustapich, T., & Ranade, S. C. (2025). Orthopaedic management in Duchenne muscular dystrophy. Journal of the Pediatric Orthopaedic Society of North America, 10, 100154. https://pmc.ncbi.nlm.nih.gov/articles/PMC12088117/
• Birnkrant, D. J., et al. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. The Lancet Neurology, 17(3), 251–267. https://doi.org/10.1016/S1474-4422(18)30024-3
• Birnkrant, D. J., et al. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 2: Respiratory, cardiac, bone health, and orthopaedic management. The Lancet Neurology, 17(4), 347–361. https://doi.org/10.1016/S1474-4422(18)30025-5

Diabetes can make an ordinary foot injury unusually serious. A blister, pressure mark, or small cut may develop into an ulcer when sensation is reduced or circulation is impaired. Carefully chosen socks offer a simple layer of protection between the skin and footwear. However, not everyone with diabetes needs an expensive product labelled “diabetic”. The important considerations are appropriate fit, gentle construction, moisture management, and compatibility with shoes. Special socks are particularly useful for people with neuropathy, fragile skin, deformity, or previous foot problems, but they should always complement, rather than replace, comprehensive foot care.

Why diabetic feet need protection

One reason for protective socks is peripheral neuropathy, a complication that damages nerves in the feet. People may lose the ability to feel pain, pressure, temperature, or rubbing. Consequently, a prominent sock seam or a wrinkle inside a shoe can injure the skin without causing a warning sensation. Continued walking exposes the same area to repeated stress, potentially turning a minor irritation into an open wound. Socks with smooth interiors and a secure, comfortable fit help minimise avoidable irritation, especially when the wearer cannot reliably detect discomfort.

Peripheral arterial disease can further increase risk by reducing blood flow to the feet. Poor circulation limits the oxygen and nutrients available for tissue repair, making wounds more difficult to heal. Diabetes may also impair immune responses, increasing the consequences of infection. These problems explain why preventing skin damage matters so much. Nevertheless, socks do not restore arterial circulation, treat neuropathy, or guarantee protection against ulcers. Their role is to reduce some everyday sources of mechanical irritation while supporting a broader prevention strategy.

Smooth construction and comfortable fit

A valuable feature of many diabetes-friendly socks is seamless construction or a flat, unobtrusive toe seam. Thick seams can concentrate pressure over toes, particularly when shoes are tight or toe deformities are present. Soft fabrics and smooth stitching reduce potential rubbing. Socks should also remain in position without bunching, folding, or slipping. An oversized sock can form wrinkles, while an undersized sock may compress the toes. Choosing the correct size is therefore more important than simply selecting a product with a medical-sounding label.

Non-binding tops are another useful feature. Tight elastic cuffs may leave deep indentations or irritate vulnerable skin, especially when the ankles are swollen. A gently fitted cuff can hold the sock in place without creating a narrow pressure band. However, excessively loose socks can slip and bunch, so “non-binding” should not mean poorly fitted. People whose swelling changes considerably throughout the day may need professional advice about sock sizing and the underlying cause of swelling rather than repeatedly buying larger socks.

Moisture control and cushioning

Moisture management also deserves attention. Feet enclosed in shoes may become sweaty, and persistently damp skin is more susceptible to maceration and friction damage. Moisture-wicking fabrics help move perspiration away from the skin. Suitable synthetic fibres, wool, or well-designed blends can be useful, although performance depends on the complete fabric construction rather than one ingredient alone. Cotton is not automatically unsuitable, but it can retain moisture when wet. Socks should be changed daily, and more frequently if damp, with feet washed and dried carefully, including between the toes.

Some specialist socks provide cushioning beneath the heel and forefoot. Padding may improve comfort and redistribute pressure, particularly over prominent bones or areas with reduced natural cushioning. Yet thicker is not always better. Extra bulk inside a snug shoe can crowd the toes and increase pressure instead of reducing it. Socks and footwear must therefore be assessed together. People at high ulcer risk may require professionally prescribed footwear or insoles; padded socks are not a substitute for these interventions or for treatment that offloads an existing ulcer.

Practical advantages and important distinctions

White or light-coloured socks can make blood or wound drainage easier to notice. This may alert someone to an unnoticed blister or injury, particularly when protective sensation is absent. However, sock colour does not prevent wounds, and clean socks do not prove that the feet are healthy. Daily inspection remains essential. Socks should be checked for rough seams, holes, worn padding, and trapped debris before use. Wearing socks with properly fitted shoes is generally safer than wearing shoes without socks, while socks alone offer inadequate protection for walking barefoot around the home.

Diabetic socks must also be distinguished from compression stockings. Most diabetes-friendly socks aim to protect the skin without applying therapeutic compression. Compression stockings deliberately exert pressure and may help selected people with venous disease or swelling. Diabetes itself does not automatically prohibit compression, but significant arterial disease can make inappropriate compression dangerous. Anyone considering compression, especially with poor circulation, an ulcer, or unexplained swelling, should seek clinical assessment. Claims that ordinary diabetic socks “improve circulation” should be viewed cautiously unless a specific benefit is supported by appropriate evidence.

Evidence and individual needs

The evidence supporting specialist socks is less robust than their marketing sometimes suggests. A 2026 systematic review found limited evidence and poor methodological quality in available clinical studies. Laboratory improvements in cushioning, friction, or moisture handling do not necessarily demonstrate fewer ulcers or amputations. Similarly, antimicrobial fibres should not be assumed to prevent clinical infection. People with normal sensation, adequate circulation, and no foot deformity may do well with ordinary socks that meet appropriate design requirements. Selection should reflect individual risk, comfort, affordability, and professional advice rather than branding alone. Regular review is important because foot risk can change over time. A person who previously needed only ordinary socks may require additional protection after developing sensory loss, deformity, swelling, or a history of ulceration.

Ultimately, special socks are useful because they can reduce avoidable irritation, manage moisture, and provide carefully selected cushioning for vulnerable feet. Their benefits depend on correct fit and suitable footwear. They belong alongside daily foot checks, regular clinical examinations, diabetes management, and prompt attention to injuries. A new wound, spreading redness, discharge, or a hot, swollen foot requires urgent assessment, even without pain. The safest message is not that every person with diabetes must buy special socks, but that everyone should wear socks suited to their foot health and level of risk.

---

References

• American Diabetes Association. 8 Tips to Protect Your Feet with Diabetes. https://diabetes.org/health-wellness/diabetes-and-your-feet/8-tips-protect-your-feet
• Diabetic Socks: A Systematic Review of the Literature and Commercially Available Products. Diabetes/Metabolism Research and Reviews (2026), 42(2), e70138. https://doi.org/10.1002/dmrr.70138